Ticker: AGTX

Agentix Corp. (PINK: AGTX) - Quick take Agentix Corp. is a clinical-stage biotech with no reported revenue for the quarter ended June 30, 2025. The quarter shows rising R&D activity but weak liquidity, significant related‑party funding and a formal going‑concern disclosure. Key facts & figures * ...

**Agentix Corp. (PINK: AGTX)** has recently released its quarterly report for the period ended December 31, 2024. The company is in the clinical-stage biotechnology sector, focusing on therapeutic agents for metabolic diseases. Here are the key points from their latest income statement and overal...